Clinical consequences of the biphasic elimination kinetics for the diuretic effect of furosemide and its acyl glucuronide in humans

Journal of Pharmacy and Pharmacology

Volumn 51, Issue 3, 1999, Pages 239-248

  Vree, Tom B ^a   Van Der Ven, André J A M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; FUROSEMIDE; FUROSEMIDE ACYLGLUCURONIDE; GLUCURONIDE; UNCLASSIFIED DRUG;

ACIDURIA; CHLORIDE TRANSPORT; CONTROLLED STUDY; DIURESIS; DRUG ACCUMULATION; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG EFFECT; DRUG ELIMINATION; DRUG GLUCURONIDATION; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG MECHANISM; DRUG URINE LEVEL; ENTEROHEPATIC CIRCULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; KIDNEY TUBULE; MICTURITION; NORMAL HUMAN; POTASSIUM TRANSPORT; REVIEW; SODIUM TRANSPORT; URINARY EXCRETION; URINE RETENTION;

EID: 0032930605     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357991772402     Document Type: Review

References (86)

1. Allison, M. E. M., Kennedy, A. C. (1971) Diuretics in chronic renal disease: a study of high dosage frusemide. Clin. Sci. 41: 171-187
2. Alván, G., Helleday, L., Lindholm, A., Sanz, E., Villén, T. (1990) Diuretic effect and diuretic efficiency after intravenous dosage of frusemide. Br. J. Clin. Pharmacol. 29: 215-219
3. Alván, G., Paintaud, G., Eckemäs, S. Å., Grahnén, A. (1992) Discrepancy between bioavailability as estimated from urinary recovery of furosemide and total diuretic effect. Br. J. Clin. Pharmacol. 34: 47-52
4. Beerman, B., Dalén, E., Lindström, B., Rosén, A. (1975) On the fate of furosemide in man. Eur. J. Clin. Pharmacol. 9: 51-61
5. Beerman, B., Dalén, E., Lindström, B. (1977) Elimination of furosemide in healthy subjects and in those with renal failure. Clin. Pharmacol. Ther. 22: 70-78
6. Benet, L. Z. (1979) Pharmacokinetics/pharmacodynamics of furosemide in man, a review. J. Pharmacokin. Biopharm. 7: 1-27
7. Benet, L. Z., Smith, D. E., Lin, E. T., Vincenti, F., Gambertoglio, J. G. (1983) Furosemide assays and disposition in healthy volunteers and renal transplant patients. Fed. Proc. 42: 1695-1698
8. Branch, R. A., Roberts, C. J. C., Homeida, M., Levine, D. (1977) Determinants of response to furosemide in normal subjects. Br. J. Clin. Pharmacol. 4: 121-127
9. Brater, D. C. (1978) Effects of probenecid on furosemide response. Clin. Pharmacol. Ther. 24: 548-554
10. Brater, D. C. (1991) Clinical pharmacology of loop diuretics. Drugs 41 (Suppl. 3): 14-22
11. Brater, D. C., Chennavasin, P., Selwell, R. (1980) Furosemide in patients with heart failure: shift in dose response curves. Clin. Pharmacol. Ther. 28: 182-186
12. Brater, D. C., Anderson, S. A., Brown-Cartwright, D. (1986) Response to furosemide in chronic renal insufficiency: rationale for limited doses. Clin. Pharmacol. Ther. 40: 134-139
13. Burg, M. B. (1976) Tubular chloride transport and the mode of action of some diuretics. Kidney Int. 9: 189-197
14. Burg, M., Stoner, L., Cardinal, J., Green, N. (1973) Furosemide effects on isolated perfused tubules. Am. J. Physiol. 225: 119-124
15. Chennavasin, P., Seiwell, R., Brater, D. C., Liang, W. M. M. (1979) Pharmacodynamic analysis of the furosemide-probenecid interaction in man. Kidney Int. 16: 187-195
16. Chennavasin, P., Seiwell, R., Brater, D. C. (1980) Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man. J. Pharmacol. Exp. Ther. 215: 77-81
17. Copeland, J. G., Campbell, D. W., Plachetka, J. R., Salomon, N. W., Larson, D. F. (1983) Diuresis with continuous infusion of furosemide after cardiac surgery. Am. J. Surg. 146: 796-799
18. Cutler, R. E., Forrey, A. W., Christopher, T. G., Kimpel, B. (1974) Pharmacokinetics of furosemide in normal subjects and functionally anephric patients. Clin. Pharmacol. Ther. 15: 588-596
19. Dikshit, K., Vyden, J. K., Forrester, J. S. (1973) Renal and extra renal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N. Engl. J. Med. 288: 1087-1090
20. Dormans, T. P. J., VanMeyel, J. J. M., Gerlag, P. G. G., Tan, Y., Russel, F. G. M., Smits, P. (1996) Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J. Am. Coll. Cardiol. 28: 376-382
21. Duchin, K. L., Peterson, L. N., Burke, T. J. (1977) Effect of furosemide on renal autoregulation. Kidney Int. 12: 379-386
22. Faed, M. (1984) Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs. Drug Metab. Rev. 15: 1213-1219
23. Gerlag, P. G. G., VanMeyel, J. J. M. (1988) High dose furosemide in the treatment of refractory congestive heart failure. Arch. Intern. Med. 148: 286-291
24. Gray, J. M. B., Henry, D. A., Lawson, D. H., Tilstone, W. J. (1978) Continuous infusion of frusemide in refractory oedema. Br. J. Pharmacol. 64: 453P
25. Greger, R., Schlatter, E. (1983) Cellular mechanisms of the action of loop diuretics on the thick ascending limb of Henle's loop. Klin. Wschrft. 61: 1019-1027
26. Hammarlund, M. M., Paalzow, L. K., Odlind, B. (1984) Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis. Eur. J. Clin. Pharmacol. 26: 197-207
27. Hammarlund-Udenaes, M., Benet, L. Z. (1989) Furosemide pharmacokinetics and pharmacodynamics in health and disease, an update. J. Pharmacokin. Biopharm. 17: 1-46
28. Heidenreich, O., Greven, J., Heintze, K. (1983) Diuretic agents: actions on a molecular level. Clin. Exp. Hyper. Theory Practice A5: 177-192
29. Heidland, A., Henneman, H. (1969) Aktivierung des sympathicoadrenalen Systems nach Diuretica-Beziehungen zum saldiuretischen Effekt und Glomerulumfiltrat. Klin. Wschrft. 47: 518-524
30. Homeida, M., Roberts, C., Branch, R. A. (1977) Influence of probenecid and spironolactone on furosemide kinetics and dynamics in man. Clin. Pharmacol. Ther. 22: 402-409
31. Honari, J., Blair, A. D., Cutler, R. E. (1977) Effects of probenecid on furosemide kinetics and natriuresis in man. Clin. Pharmacol. Ther. 22: 395-401
32. Jacobson, H. R., Kokko, J. P. (1976) Diuretics: sites and mechanisms of action. Annu. Rev. Pharmacol. Toxicol. 16:201-214
33. Kaissling, B., Bachmann, S., Kriz, W. (1985) Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am. J. Physiol. 248: F374-F381
34. Kang, M. J., Yoon, W. H., Kim, O. N., Lee, M. G. (1995) Effects of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of furosemide in rats. J. Clin. Pharm. Ther. 20: 13-21
35. Kaojarern, S., Day, B., Brater, D. C. (1982) The time course of delivery of furosemide into urine: an independent determinant of overall response. Kidney Int. 22: 69-74
36. Kindler, J. (1993) Torasemide in advanced renal failure. Cardovasc. Drugs Ther. 7: 75-80
37. Knauf, H., Spahn, H., Mutschler, E. (1991) The loop diuretic torasemide in chronic renal failure. Pharmacokinetics and pharmacodynamics. Drugs 41 (Suppl. 3): 23-34
38. Krasma, M. J., Scott, G. E., Scholz, P. M., Spotnitz, A. J., Mackenzie, J. W., Penn, F. (1986) Postoperative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy. Chest 89: 294-295
39. Lahav, M., Regev, A., Ra'anani, P., Theodor, E. (1992) Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. Chest 102: 725-731
40. Lawson, D. H., Gray, J. M. B., Henry, D. A., Tilstone, W. J. (1978) Continuous infusion of frusemide in refractory oedema. Br. Med. J. 2: 476
41. Lee, M. G., Li, T., Chiou, W. L. (1986) Effect of intravenous infusion time on the pharmacokinetics and pharmacodynamics of the same total dose of furosemide. Biopharm. Drug Dispos. 7: 537-547
42. Magovern, J. A., Magovern, G. J. (1990) Diuresis in hemodynamically compromised patients: continuous furosemide infusion. Ann. Thorac. Surg. 50: 482-484
43. Martin, U., Winney, R. J., Prescott, L. F. (1995) Furosemide disposition in patients on CAPD. Eur. J. Clin. Pharmacol. 48: 385-390
44. Murray, M. D., Haag, K. M., Black, P. K., Hall, S. D., Brater, D. C. (1997) Variable furosemide absorption and poor predictability of response in elderly patients. Pharmacotherapy 17: 98-106
45. Paintaud, G., Alván, G., Eckernäs, S. Å., Wakelkamp, M., Grahnén, A. (1995) The influence of food intake on the effect of two controlled release formulations of furosemide. Biopharm. Drug Dispos. 16: 221-232
46. Pichette, V., DuSouich, P. (1996) Role of the kidneys in the metabolism of furosemide: its inhibition by probenecid. J. Am. Soc. Nephrol. 7: 345-349
47. Pichette, V., Geadah, D., DuSouich, P. (1996) The influence of moderate hypoalbuminaemia on the renal metabolism and dynamics of furosemide in the rabbit. Br. J. Pharmacol. 119: 885-890
48. Ponto, L. L. B., Schoenwald, R. D. (1990) Furosemide. A pharmacokinetic/pharmacodynamic review. Clin. Pharmacokin. 18: 381-408
49. Puschett J. R., Goldberg M. (1968) The acute effects on acid and electrolyte excretion in man. J. Lab. Clin. Med. 71: 666-677
50. Rachmel, A., Hazelton, G. A., Yergey, A. L., Liberato, D. J. (1985) Furosemide 1-O-acyl glucuronide. In vitro biosynthesis and pH-dependent isomerization to β-glucuronidase-resistant forms. Drug Metab. Dispos. 13: 705-710
51. Reyes, A. J. (1991) Effects of diuretics on outputs and flows of urine and urinary solutes in healthy volunteers. Drugs 41 (Suppl. 3): 35-59
52. Reyes, A. J., Leary, W. P. (1993) Clinicopharmacological reappraisal of the potency of diuretics. Cardiovasc. Drugs Ther. 7: 23-28
53. Risler, T., Krämer, B., Müller, G. A. (1991) The efficacy of diuretics in acute and chronic renal failure. Drugs 41 (Suppl. 3): 69-71
54. Ritz, E., Fliser, D., Nowicki, M., Stein, G. (1994) Treatment with high doses of loop diuresis in chronic renal failure. Nephrol. Dial. Transplant. 9 (Suppl. 3): 40-43
55. Riva, E., Fossali, E., Bettinelli, A. (1982) Kinetics of furosemide in children with chronic renal failure undergoing regular haemodialysis. Eur. J. Clin. Pharmacol. 21: 303-306
56. Rudy, D. W., Voelker, J. R., Greene, P. K., Esparza, F. A., Brater, D. C. (1991) Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy. Ann. Intern. Med. 115: 360-366
57. Russo, D., Memoli, B., Andreucci, V. E. (1992) The place of loop diuretics in the treatment of acute and chronic renal failure. Clin. Nephrol. 38 (Suppl. 1): S69-S73
58. Seeley, J. F., Dirks, J. H. (1977) Site of action of diuretic drugs. Kidney Int. 11: 1-8
59. Sekinawa, H., Yagi, N., Oda, K., Kenmotsu, H., Takada, M., Chen, H. F., Lin, E. T., Benet, L. Z. (1995) Biliary excretion of furosemide glucuronides in rabbits. Biol. Pharm. Bull. 18: 447-453
60. Sjöström, A., Odlind, B. G., Beermann, B. A., Hammarlund-Udenaes, M. (1988) On the mechanism of acute tolerance to furosemide diuresis. Scand. J. Urol. Nephrol. 22: 133-140
61. Sjöström, A., Odlind, B. G., Beermann, B. A., Karlberg, B. E. (1989) Pharmacokinetics and effects of frusemide in patients with nephrotic syndrome. Eur. J. Clin. Pharmacol. 37: 173-180
62. Smith, D. E., Gee, W. L., Brater, D. C., Lin, E. T., Benet, L. Z. (1980) Preliminary evaluation of furosemide-probenecid interaction in humans. J. Pharm. Sci. 69: 571-575
63. Swan, S. K. (1994) Diuretic strategies in patients with renal failure. Drugs 48: 380-385
64. Swan, S. K., Brater, D. C. (1993) Clinical pharmacology of loop diuretics and their use in chronic renal insufficiency. J. Nephrol. 6: 118-123
65. Taylor, S. H. (1993) Diuretics in heart failure: some knowns and unknowns. J. Cardiovasc. Pharmacol. 22 (Suppl. 3): S40-S50
66. VanMeyel, J. J. M., Smits, P., Russel, F. G. M., Gerlag, P. G. G., Tan, Y., Gribnau, F. W. J. (1992) Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers. Clin. Pharmacol. Ther. 51: 440-444
67. VanMeyel, J. J. M., Smits, P., Dormans, T., Gerlag, P. G. G., Russel, F. G. M., Gribnau, F. W. J. (1994) Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance. J. Int. Med. 235: 329-334
68. VanOlden, R. W., VanMeyel, J. J. M., Gerlag, P. G. G. (1992) Acute and long term effects of therapy with high dose furosemide in chronic hemodialysis patients. Am. J. Nephrol. 12: 351-356
69. VanOlden, R. W., VanMeyel, J. J., Gerlag, P. G. (1995) Sensitivity of residual nephrons to high dose furosemide described by diuretic efficiency. Eur. J. Clin. Pharmacol. 47: 483-488
70. Vergés, J., Héroux, L., Maurice, H., DuSouich, P. (1995) Extrahepatic metabolism of frusemide in anaesthetized rabbits. Br. J. Pharmacol. 116: 2407-2412
71. Voelker, J. R., Cartwright-Brown, D., Anderson, S., Leinfelder, J., Sica, D. A., Kokko, J. P., Brater, D. C. (1987) Comparison of loop diuretics in patients with chronic renal insufficiency. Kidney Int. 32: 572-578
72. Vree, T. B., Van Kerrebroeck, P. E. V. (1994) Geneesmiddelen en urine (in)continentie. Tijdschrft Geneesmiddel Onderzoek T.G.O. 19: 8-13
73. Vree, T. B., Vander Kleijn, E., Gusdorf, C. F., Zum Vörde Sive Vörding, J. G. M. (1983a) Biologische beschikbaarheid van twee furosemide preparaten (biovailability of two furosemide preparations). Pharm. Weekbl. 118: 121-123
74. Vree, T. B., Hekster, Y. A., VanDalen, R. (1983b) Some consequences of drug choice and dosage regimen for patients with impaired kidney function. Drug Intell. Clin. Pharm. 17: 267-273
75. Vree, T. B., Beneken Kolmer, E. W. J., Wuis, E. W., Hekster, Y. A. (1992a) Capacity limited renal glucuronidation of probenecid by humans. A pilot Vmax finding study. Pharm. Weekbl. Sci. 14: 325-331
76. Vree, T. B., Hekster, Y. A., Anderson, P. G. (1992b) Contribution of the human kidney to the metabolic clearance of drugs. Ann. Pharmacother. 26: 1421-1428
77. Vree, T. B., Vanden Biggelaar-Martea, M., Verwey-VanWissen, C. P. W. G. M., Vree, M. L., Guelen, P. J. M. (1993a) Pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen and their acyl glucuronides in humans. Effect of cimetidine. Br. J. Clin. Pharmacol. 35: 467-472
78. Vree, T. B., Vanden Biggelaar-Martea, M., Verwey-VanWissen, C. P. W. G. M., Vree, J. B., Guelen, P. J. M. (1993b) Pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen and their acyl glucuronides in humans. Biopharm. Drug Dispos. 14: 491-502
79. Vree, T. B., Vanden Biggelaar-Martea, M., Verwey-VanWissen, C. P. W. G. M. (1994) Determination of furosemide with its acyl glucuronide in human plasma and urine by means of direct gradient high performance liquid chromatographic analysis with fluorescence detection. Preliminary pharmacokinetics and effect of probenecid. J. Chromatogr. 655: 53-62
80. Vree, T. B., Vanden Biggelaar-Martea, M., Verwey-VanWissen, C. P. W. G. M. (1995a) Probenecid inhibits the renal clearance of frusemide and its acyl glucuronide. Br. J. Clin. Pharmacol. 39: 692-695
81. Vree, T. B., Vanden Biggelaar-Martea, M., Verwey-VanWissen, C. P. W. G. M. (1995b) Frusemide and its acyl glucuronide show a short and long phase in elimination kinetics and pharmacodynamic effect in man. J. Pharm. Pharmacol. 47: 964-969
82. 1-glucuronide conjugates in healthy human volunteers. Clin. Drug Invest. 9: 43-53
83. Vree, T. B., Vanden Biggelaar-Martea, M., Verwey-VanWissen, C. P. W. G. M., van der Ven, A. J. A. M. (1996) Pharmacokinetics and pharmacodynamics of furosemide and its acyl glucuronide in humans. A quest for the in vivo activity of the acyl glucuronide. J. Appl. Ther. 1: 137-144
84. Wakelkamp, M., Alván, G., Gabrielsson, J., Paintaud, G. (1996) Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration. Clin. Pharmacol. Ther. 60: 75-78
85. Wittner, N., Di Stefano, A., Wangemann, P., Greger, R. (1991) How do loop diuretics act? Drugs 41 (Suppl. 3): 1-13
86. Yagi, N., Kiuchi, T., Terashima, Y., Kenmotsu, H., Sekinawa, H., Takada, M. (1996) Bioavailability and diuretic effect of furosemide following administration of tablets and retarded capsules to human subjects. Biol. Pharm. Bull. 19: 616-622